Elevance Health, Inc. (LON:0HG8)
London
· Delayed Price · Currency is GBP · Price in USD 274.29
-11.50 (-4.02%)
At close: Mar 9, 2026
Elevance Health Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 47,740 | 57,884 | 68,340 | 86,985 | 101,678 | 83,089 | Upgrade
|
| Market Cap Growth | -32.06% | -15.30% | -21.44% | -14.45% | 22.37% | 42.06% | Upgrade
|
| Enterprise Value | 65,217 | 75,358 | 83,825 | 98,689 | 114,852 | 96,614 | Upgrade
|
| PE Ratio | 11.35 | 13.76 | 14.31 | 18.51 | 20.79 | 18.27 | Upgrade
|
| PS Ratio | 0.32 | 0.39 | 0.48 | 0.65 | 0.78 | 0.81 | Upgrade
|
| PB Ratio | 1.46 | 1.77 | 2.07 | 2.81 | 3.37 | 3.11 | Upgrade
|
| P/FCF Ratio | 20.24 | 24.55 | 18.80 | 16.38 | 16.91 | 15.46 | Upgrade
|
| P/OCF Ratio | 14.98 | 18.16 | 14.73 | 13.75 | 14.59 | 13.45 | Upgrade
|
| EV/Sales Ratio | 0.44 | 0.51 | 0.59 | 0.73 | 0.88 | 0.94 | Upgrade
|
| EV/EBITDA Ratio | 9.51 | 11.22 | 9.97 | 11.48 | 14.51 | 13.29 | Upgrade
|
| EV/EBIT Ratio | 10.53 | 12.22 | 10.64 | 12.71 | 16.35 | 14.49 | Upgrade
|
| EV/FCF Ratio | 27.65 | 31.96 | 23.05 | 18.58 | 19.10 | 17.98 | Upgrade
|
| Debt / Equity Ratio | 0.74 | 0.74 | 0.78 | 0.66 | 0.69 | 0.67 | Upgrade
|
| Debt / EBITDA Ratio | 3.57 | 3.57 | 3.01 | 2.34 | 2.58 | 2.37 | Upgrade
|
| Debt / FCF Ratio | 10.32 | 10.32 | 7.07 | 3.84 | 3.46 | 3.30 | Upgrade
|
| Net Debt / Equity Ratio | 0.53 | 0.53 | 0.58 | 0.49 | 0.49 | 0.53 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.57 | 2.57 | 2.27 | 1.78 | 1.85 | 1.95 | Upgrade
|
| Net Debt / FCF Ratio | 7.33 | 7.33 | 5.25 | 2.87 | 2.44 | 2.63 | Upgrade
|
| Quick Ratio | 1.41 | 1.41 | 1.32 | 1.30 | 1.27 | 1.33 | Upgrade
|
| Current Ratio | 1.54 | 1.54 | 1.45 | 1.44 | 1.40 | 1.47 | Upgrade
|
| Asset Turnover | 1.67 | 1.67 | 1.57 | 1.62 | 1.56 | 1.51 | Upgrade
|
| Return on Equity (ROE) | 13.25% | 13.25% | 14.77% | 15.82% | 16.25% | 17.74% | Upgrade
|
| Return on Assets (ROA) | 4.35% | 4.35% | 5.46% | 5.84% | 5.28% | 6.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.15% | 9.31% | 10.72% | 12.12% | 10.79% | 12.14% | Upgrade
|
| Earnings Yield | 8.81% | 7.27% | 6.99% | 5.40% | 4.81% | 5.47% | Upgrade
|
| FCF Yield | 4.94% | 4.07% | 5.32% | 6.11% | 5.92% | 6.47% | Upgrade
|
| Dividend Yield | 1.84% | 1.95% | 1.80% | 1.30% | 1.04% | 1.02% | Upgrade
|
| Payout Ratio | 27.43% | 27.00% | 25.22% | 23.30% | 20.85% | 17.93% | Upgrade
|
| Buyback Yield / Dilution | 3.56% | 3.56% | 1.90% | 2.22% | 1.62% | 2.95% | Upgrade
|
| Total Shareholder Return | 5.35% | 5.51% | 3.69% | 3.53% | 2.66% | 3.97% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.